Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Subscribe To Our Newsletter & Stay Updated